To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Madrigal Pharmaceuticals is ...
Madrigal Pharmaceuticals (MDGL) is back on investors radar after Rezdiffra s early launch exceeded expectations, putting the MASH therapy on a path toward blockbuster level sales and reshaping the ...
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Growth Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equities hit a record high in the ...
Madrigal (shoulder) cleared waivers and opted for free agency Thursday. Madrigal missed the full 2025 campaign after undergoing surgery in February to repair a fractured left shoulder. The infielder, ...
Shares of Madrigal Pharmaceuticals (MDGL) traded sharply higher for the second straight session on Wednesday after Cantor Fitzgerald upgraded the company, arguing that the commercial rollout of its ...
Madrigal Pharmaceuticals' Rezdiffra generated sales of $287 million in the third quarter for a 35% sequential jump from Q2. In just its fifth full quarter on the market, the world’s first treatment ...
Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...
Genndy Tartakovsky posts animation test to "change studio's mind" about his medieval mech suit movie
Animator Genndy Tartakovsky has bounced back and forth for years between more mainstream, studio-friendly projects (most notably the Hotel Transylvania films, but also his well-loved work on Star Wars ...
Acclaimed animator and director Genndy Tartakovsky spent the last 17 years ensuring that his passion project, Fixed, would eventually become a reality. Having finally realized that dream with ...
Madrigal Pharmaceuticals (NASDAQ:MDGL) has received conditional marketing approval from the European Commission for Rezdiffra (resmetirom) for non-cirrhotic metabolic dysfunction-associated ...
July 30 (Reuters) - U.S. drugmaker Madrigal Pharmaceuticals (MDGL.O), opens new tab has struck a licensing deal with CSPC Pharmaceutical Group (1093.HK), opens new tab that could be worth more than $2 ...
PHOENIX (AZFamily) — A Valley favorite has reopened at a new location after a fire destroyed its original restaurant last year. The fire devastated Cocina Madrigal in March 2024. Investigators say it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback